Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: conduct book
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
product_txtF_mv:"National Center for Biotechnology Information"
Search alternatives
:
conduct book »
conduct both
,
conduct good
,
contact book
Showing
1
-
20
of
139
Search:
'conduct book'
,
query time: 1.80s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Lumacaftor/Ivacaftor (Orkambi -- Vertex Pharmaceuticals (Canada) Incorporated) : indication : cystic fibrosis, F508del-cystic f...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Lumacaftor/Ivacaftor (Orkambi -- Vertex Pharmaceuticals (Canada) Incorporated) : indication : cystic fibrosis, F508del-cystic f...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
3
Pharmacoeconomic review report: Lumacaftor/Ivacaftor (Orkambi) (Vertex pharmaceuticals (Canada) Incorporated) : indication, for the treatment of cystic fibrosis in patients 6 years...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
4
Standardized allergenic extract, timothy grass (phleum pratense) (GRASTEK) (sublingual tablet 2,800 BAU)
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...The objective is to
conduct
a systematic review of the beneficial and harmful effects of Timothy...
”
Read Now
5
Point-of-care testing of international normalized ratio for patients on oral anticoagulant therapy : project protocol
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... of economic evaluation studies will be
conducted
. CADTH will also
conduct
a primary economic analysis...
”
Read Now
6
Standardized allergenic extract, timothy grass (phleum pratense) (GRASTEK) (sublingual tablet 2,800 BAU)
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...The objective is to
conduct
a systematic review of the beneficial and harmful effects of Timothy...
”
Read Now
7
Drugs for pulmonary arterial hypertension : comparative efficacy, safety, and cost-effectiveness
by
Tran, Khai
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...The objective of this therapeutic review is to
conduct
a systematic review to assess...
”
Read Now
8
Drugs for pulmonary arterial hypertension : comparative efficacy, safety, and cost-effectiveness
by
Tran, Khai
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...The objective of this therapeutic review is to
conduct
a systematic review to assess...
”
Read Now
9
Point-of-care testing of international normalized ratio for patients on oral anticoagulant therapy : project protocol
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... of economic evaluation studies will be
conducted
. CADTH will also
conduct
a primary economic analysis...
”
Read Now
10
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy : a health technology assessment
by
Kanga, Ismat
Published 2018
CADTH
“
...The purpose of this health technology assessment (HTA) is to
conduct
a systematic assessment...
”
Read Now
11
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy : a health technology assessment
by
Kanga, Ismat
Published 2018
CADTH
“
...The purpose of this health technology assessment (HTA) is to
conduct
a systematic assessment...
”
Read Now
12
Axicabtagene ciloleucel for large B-cell lymphoma: Implementation and ethics project protocol
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... encompasses a plan to
conduct
an Implementation Analysis, an Ethics Review and Patient and Stakeholder Input...
”
Read Now
13
Axicabtagene ciloleucel for large B-cell lymphoma: Implementation and ethics project protocol
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... encompasses a plan to
conduct
an Implementation Analysis, an Ethics Review and Patient and Stakeholder Input...
”
Read Now
14
Somatropin (Genotropin) for subcutaneous injection : the treatment of short stature associated with Turner syndrome in patients whose epiphyses are not closed
Published 2014
CADTH
“
... was to
conduct
a systematic review of the benefits and harms of Genotropin compared with other available...
”
Read Now
15
Common drug review new combination product submission: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza) : (Janssen Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... of this review is to
conduct
an appraisal of the clinical evidence and pharmacoeconomic evaluation submitted...
”
Read Now
16
Delivery of electroconvulsive therapy in non-hospital settings : a review of the safety and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... survey of 172 centers identified as
conducting
ECT indicates that among registered healthcare...
”
Read Now
17
Common drug review new combination product submission: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza) : (Janssen Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... of this review is to
conduct
an appraisal of the clinical evidence and pharmacoeconomic evaluation submitted...
”
Read Now
18
Delivery of electroconvulsive therapy in non-hospital settings : a review of the safety and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... survey of 172 centers identified as
conducting
ECT indicates that among registered healthcare...
”
Read Now
19
Pharmacoeconomic report: Eculizumab (Soliris) : Alexion Pharma Canada Corporation : indication : adult patients with generalized myasthenia gravis
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
20
Needle or open fasciotomy for Dupuytren's contracture : a review of the comparative efficacy, safety, and cost-effectiveness : an update
Published 2013
Canadian Agency for Drugs and Technologies in Health
1
2
3
4
5
6
7
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
610 - Medicine & health
84
330 - Economics
48
140 - Specific philosophical schools
10
170 - Ethics
4
580 - Plants (Botany)
4
380 - Commerce, communications & transportation
2
more ...
600 - Technology
2
700 - The arts; fine & decorative arts
2
800 - Literature & rhetoric
2
100 - Philosophy & psychology
1
see all ...
less ...
Language
English
139
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
14
Young, Calvin
10
Campbell, Kaitryn
8
Tran, Khai
5
De Angelis, Gino
4
more ...
Ho, Chuong
4
Klarenbach, Scott
3
Adcock, Lorna
2
Argáez, Charlene
2
Assasi, Nazila
2
CADTH Canadian Drug Expert Committee
2
Chao, Yi-Sheng
2
Dulong, Camille
2
Farrah, Kelly
2
Kanga, Ismat
2
Lachance, Chantelle
2
MacDougall, Danielle
2
Narain, Tasha
2
Picheca, Lory
2
Seal, Kelsey
2
Spry, Carolyn
2
Manns, Braden
1
Moulton, Kristen
1
Rabb, Danielle
1
Santesso, Nancy
1
So, Helen
1
Tonelli, Marcello
1
see all ...
less ...
Recently Uploaded
Last Month
9
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&lookfor=conduct+book&type=AllFields
Send by Email
×
Loading...